CRM
AGN

Cramer Rosenthal McGlynn’s Allergan plc AGN Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-385,064
Closed -$56.4M – 133
2019
Q1 		$56.4M Buy
385,064
+50,166
+15% +$7.27M 1.34% 23
2018
Q4 		$44.8M Sell
334,898
-118,625
-26% -$19.4M 1.13% 34
2018
Q3 		$86.4M Sell
453,523
-188,766
-29% -$34.7M 1.65% 10
2018
Q2 		$107M Sell
642,289
-55,962
-8% -$8.98M 1.92% 3
2018
Q1 		$118M Buy
698,251
+92,992
+15% +$15.6M 1.92% 4
2017
Q4 		$99M Buy
605,259
+179,489
+42% +$32.2M 1.59% 7
2017
Q3 		$87.3M Buy
425,770
+145,099
+52% +$33.7M 1.4% 14
2017
Q2 		$68.2M Buy
280,671
+9,726
+4% +$2.29M 1.04% 26
2017
Q1 		$64.7M Sell
270,945
-258,380
-49% -$60.2M 0.99% 27
2016
Q4 		$111M Buy
529,325
+216,533
+69% +$44.9M 1.65% 4
2016
Q3 		$72M Sell
312,792
-55,351
-15% -$13.5M 1.11% 15
2016
Q2 		$85.1M Buy
368,143
+150,269
+69% +$34.6M 1.37% 6
2016
Q1 		$58.4M Buy
217,874
+9,496
+5% +$2.72M 0.92% 34
2015
Q4 		$65.1M Buy
208,378
+103,438
+99% +$30.8M 0.98% 30
2015
Q3 		$28.5M Sell
104,940
-15,965
-13% -$4.9M 0.38% 100
2015
Q2 		$36.7M Sell
120,905
-9,990
-8% -$2.98M 0.45% 99
2015
Q1 		$39M Buy
130,895
+86,295
+193% +$24.6M 0.44% 100
2014
Q4 		$11.5M Buy
+44,600
New +$11.1M 0.12% 159

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cramer Rosenthal McGlynn's AGN Position: Q2 2019 in Review

Cramer Rosenthal McGlynn sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 385,064 shares — an estimated $56.4M sold.

Cramer Rosenthal McGlynn first reported a position in AGN in Q4 2014 and held it in 18 quarters. The position peaked at $118M in Q1 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Cramer Rosenthal McGlynn reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 385,064 Allergan plc shares in Q2 2019, an estimated $56.4M.
  • Cramer Rosenthal McGlynn first reported a position in Allergan plc in Q4 2014 and held it in 18 quarters.
  • Cramer Rosenthal McGlynn's Allergan plc position peaked at $118M in Q1 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2019, filed 13 Aug 2019.